These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 8107245

  • 1. RAZ, an Epstein-Barr virus transdominant repressor that modulates the viral reactivation mechanism.
    Furnari FB, Zacny V, Quinlivan EB, Kenney S, Pagano JS.
    J Virol; 1994 Mar; 68(3):1827-36. PubMed ID: 8107245
    [Abstract] [Full Text] [Related]

  • 2. Repression by RAZ of Epstein-Barr virus bZIP transcription factor EB1 is dimerization independent.
    Segouffin C, Gruffat H, Sergeant A.
    J Gen Virol; 1996 Jul; 77 ( Pt 7)():1529-36. PubMed ID: 8757996
    [Abstract] [Full Text] [Related]

  • 3. Physical and functional interaction of the Epstein-Barr virus BZLF1 transactivator with the retinoic acid receptors RAR alpha and RXR alpha.
    Sista ND, Barry C, Sampson K, Pagano J.
    Nucleic Acids Res; 1995 May 25; 23(10):1729-36. PubMed ID: 7784177
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA miR-BART20-5p stabilizes Epstein-Barr virus latency by directly targeting BZLF1 and BRLF1.
    Jung YJ, Choi H, Kim H, Lee SK.
    J Virol; 2014 Aug 25; 88(16):9027-37. PubMed ID: 24899173
    [Abstract] [Full Text] [Related]

  • 5. Epstein-Barr virus replicative gene transcription during de novo infection of human thymocytes: simultaneous early expression of BZLF-1 and its repressor RAZ.
    Kelleher CA, Paterson RK, Dreyfus DH, Streib JE, Xu JW, Takase K, Jones JF, Gelfand EW.
    Virology; 1995 Apr 20; 208(2):685-95. PubMed ID: 7747440
    [Abstract] [Full Text] [Related]

  • 6. Rescue of the Epstein-Barr virus BZLF1 mutant, Z(S186A), early gene activation defect by the BRLF1 gene product.
    Adamson AL, Kenney SC.
    Virology; 1998 Nov 10; 251(1):187-97. PubMed ID: 9813214
    [Abstract] [Full Text] [Related]

  • 7. 5-hydroxymethylation of the EBV genome regulates the latent to lytic switch.
    Wille CK, Nawandar DM, Henning AN, Ma S, Oetting KM, Lee D, Lambert P, Johannsen EC, Kenney SC.
    Proc Natl Acad Sci U S A; 2015 Dec 29; 112(52):E7257-65. PubMed ID: 26663912
    [Abstract] [Full Text] [Related]

  • 8. Retinoic acid is a negative regulator of the Epstein-Barr virus protein (BZLF1) that mediates disruption of latent infection.
    Sista ND, Pagano JS, Liao W, Kenney S.
    Proc Natl Acad Sci U S A; 1993 May 01; 90(9):3894-8. PubMed ID: 8387200
    [Abstract] [Full Text] [Related]

  • 9. The Epstein-Barr virus (EBV) BMRF1 promoter for early antigen (EA-D) is regulated by the EBV transactivators, BRLF1 and BZLF1, in a cell-specific manner.
    Holley-Guthrie EA, Quinlivan EB, Mar EC, Kenney S.
    J Virol; 1990 Aug 01; 64(8):3753-9. PubMed ID: 2164595
    [Abstract] [Full Text] [Related]

  • 10. Cellular differentiation regulator BLIMP1 induces Epstein-Barr virus lytic reactivation in epithelial and B cells by activating transcription from both the R and Z promoters.
    Reusch JA, Nawandar DM, Wright KL, Kenney SC, Mertz JE.
    J Virol; 2015 Feb 01; 89(3):1731-43. PubMed ID: 25410866
    [Abstract] [Full Text] [Related]

  • 11. Functional and physical interactions between the Epstein-Barr virus (EBV) proteins BZLF1 and BMRF1: Effects on EBV transcription and lytic replication.
    Zhang Q, Hong Y, Dorsky D, Holley-Guthrie E, Zalani S, Elshiekh NA, Kiehl A, Le T, Kenney S.
    J Virol; 1996 Aug 01; 70(8):5131-42. PubMed ID: 8764021
    [Abstract] [Full Text] [Related]

  • 12. Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinases.
    Adamson AL, Darr D, Holley-Guthrie E, Johnson RA, Mauser A, Swenson J, Kenney S.
    J Virol; 2000 Feb 01; 74(3):1224-33. PubMed ID: 10627532
    [Abstract] [Full Text] [Related]

  • 13. Direct BRLF1 binding is required for cooperative BZLF1/BRLF1 activation of the Epstein-Barr virus early promoter, BMRF1.
    Quinlivan EB, Holley-Guthrie EA, Norris M, Gutsch D, Bachenheimer SL, Kenney SC.
    Nucleic Acids Res; 1993 Jul 11; 21(14):1999-2007. PubMed ID: 8393562
    [Abstract] [Full Text] [Related]

  • 14. Comparing transcriptional activation and autostimulation by ZEBRA and ZEBRA/c-Fos chimeras.
    Kolman JL, Taylor N, Gradoville L, Countryman J, Miller G.
    J Virol; 1996 Mar 11; 70(3):1493-504. PubMed ID: 8627667
    [Abstract] [Full Text] [Related]

  • 15. The bZIP transactivator of Epstein-Barr virus, BZLF1, functionally and physically interacts with the p65 subunit of NF-kappa B.
    Gutsch DE, Holley-Guthrie EA, Zhang Q, Stein B, Blanar MA, Baldwin AS, Kenney SC.
    Mol Cell Biol; 1994 Mar 11; 14(3):1939-48. PubMed ID: 8114725
    [Abstract] [Full Text] [Related]

  • 16. Epstein-Barr virus (EBV) EB1/Zta protein provided in trans and competent for the activation of productive cycle genes does not activate the BZLF1 gene in the EBV genome.
    Le Roux F, Sergeant A, Corbo L.
    J Gen Virol; 1996 Mar 11; 77 ( Pt 3)():501-9. PubMed ID: 8601788
    [Abstract] [Full Text] [Related]

  • 17. The bZip dimerization domain of the Epstein-Barr virus BZLF1 (Z) protein mediates lymphoid-specific negative regulation.
    Hong Y, Holley-Guthrie E, Kenney S.
    Virology; 1997 Mar 03; 229(1):36-48. PubMed ID: 9123876
    [Abstract] [Full Text] [Related]

  • 18. The chemopreventive compound curcumin is an efficient inhibitor of Epstein-Barr virus BZLF1 transcription in Raji DR-LUC cells.
    Hergenhahn M, Soto U, Weninger A, Polack A, Hsu CH, Cheng AL, Rösl F.
    Mol Carcinog; 2002 Mar 03; 33(3):137-45. PubMed ID: 11870879
    [Abstract] [Full Text] [Related]

  • 19. CCAAT/enhancer binding protein alpha binds to the Epstein-Barr virus (EBV) ZTA protein through oligomeric interactions and contributes to cooperative transcriptional activation of the ZTA promoter through direct binding to the ZII and ZIIIB motifs during induction of the EBV lytic cycle.
    Wu FY, Wang SE, Chen H, Wang L, Hayward SD, Hayward GS.
    J Virol; 2004 May 03; 78(9):4847-65. PubMed ID: 15078966
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.